Tilsotolimod - CISMeF

Preferred Label : Tilsotolimod;

NCIt definition : A proprietary synthetic oligonucleotide-based agonist of toll-like receptor 9 (TLR9), with potential immunostimulating activity. Upon administration, tilsotolimod binds to and activates TLR9 expressed by plasmacytoid dendritic cells (pDCs) and B-cells. This initiates immune signaling pathways, activates B-cells and pDCs, and induces a cytotoxic T-lymphocyte (CTL)-mediated immune response against tumor cells. TLR9 is a member of the TLR family, which plays a fundamental role in pathogen recognition and activation of innate immunity.;

UNII : G287IC9MH3;

CAS number : 1948266-37-2;

NCI Metathesaurus CUI : CL553836;

Details

Origin ID

C152632;

UMLS CUI

C4726862;

Currated CISMeF NLP mapping
- tilsotolimod [MeSH Supplementary Concept]
- tilsotolimod [MeSH concept]
Semantic type(s)
- Nucleic Acid, Nucleoside, or Nucleotide [UMLS semantic type]
- Pharmacologic Substance [UMLS semantic type]
UMLS correspondences (same concept)
- tilsotolimod [MeSH Supplementary Concept]
concept_is_in_subset
- CTRP Agent Terminology [NCIt concept]
- CTRP Terminology [NCIt concept]
- FDA Established Names and Unique Ingredient Identifier Codes Terminology [NCIt concept]
has_salt_form
- Tilsotolimod Sodium [NCIt concept]
has_target
- Toll-Like Receptor 9 [NCIt concept]
is_free_acid_or_base_form_of
- Tilsotolimod Sodium [NCIt concept]

Keyword's position in hierarchy(ies) :

You can consult :

recommendations
documents concerning education
documents for patients